QTRX - Quanterix Corp
IEX Last Trade
10.99
0.055 0.500%
Share volume: 11,303
Last Updated: Fri 27 Dec 2024 08:29:30 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$10.94
0.06
0.50%
Fundamental analysis
8%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
0%
Performance
5 Days
3.94%
1 Month
-11.23%
3 Months
-13.04%
6 Months
-14.85%
1 Year
-60.77%
2 Year
-12.07%
Key data
Stock price
$10.99
DAY RANGE
$10.64 - $11.10
52 WEEK RANGE
$10.50 - $29.70
52 WEEK CHANGE
-$59.51
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/04/2024
Company detail
CEO: Masoud Toloue
Region: US
Website: quanterix.com
Employees: 460
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: quanterix.com
Employees: 460
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Quanterix Corporation engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; SR-X and SP-X instruments. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.
Recent news